Sage Journals: Discover world-class research

Abstract

Seizures are a common occurrence in the neonatal intensive care unit, especially among low-birth-weight infants. The efficacy and safety of standard anticonvulsants have not been evaluated extensively in the neonate. In addition, there is concern for the adverse effects of phenobarbital on long-term development. Levetiracetam has been a commonly prescribed oral anticonvulsant for the use of adjunctive therapy for partial seizures in adults with favorable tolerability, and it has been recently approved for children older than age 4 years. There are no published studies regarding the safety and efficacy of this medication in the infant population. This report describes the initiation of levetiracetam in 3 infants, aged 2 days to 3 months, for refractory seizures or intolerance to other anticonvulsants. Each patient was without seizure on levetiracetam monotherapy, and there were no adverse effects.

Keywords

levitiracetam neonate seizure

Get full access to this article

View all access options for this article.

References

Bello-Espinosa LE , Roberts SL Levitiracetam for benign epilepsy of childhood with centrotemporal spikes—three cases. Seizure. 2003;12:157-159.

Tan MJ , Appleton RE Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience. Seizure. 2004;13:142-145.

Glauser TA , Pellock JM , Bebin EM , et al. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Epilepsia. 2002;43:518-524.

Mizrahi E. Neonatal seizures and neonatal epileptic syndromes. Neurol Clin. 2001;19:427-463.

Zupanc ML Neonatal seizures. Pediatr Clin North Am. 2004; 51:961-978.

Volpe JJ Neurology of the Newborn. 4th ed. Philadelphia, Pa: WB Saunders; 2001 .

Hahn CD , Riviello JJ Neonatal seizures and EEG: electroclinical dissociation and uncoupling. Neoreviews. 2004;5:e350-e355.

Sankar R. , Holmes GL Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavior adverse effects. J Child Neurol. 2004; 19(suppl 1):S6-S14.

Klitgaard H.

Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?

Epilepsia. 2001;42(suppl 4):13-18.

10.

French JA , Kanner AM , Bautista J. , et al. Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refactory epilepsy: report of the TTA and Qss Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004;45:410-423.

11.

Koukkari MW , Guarino EJ Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol. 2004;19:944-947.

12.

Lagae L. , Buyse G. , Deconinck A. , et al. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Paediatr Neurol. 2003;7:123-128.

13.

Lagae L. , Buyse G. , Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure. 2005;14:66-71.

14.

Wheless JW , Ng Y. Levetiracetam in refractory pediatric epilepsy. J Child Neurol. 2002;17:413-415.

15.

Herranz JL , Rufo-Campos M. , Arteaga R. Effectiveness and tolerability of levetiracetam in 43 children and adolescents with epilepsy. Rev Neurol. 2003;37:1005-1008.

16.

Grosso S. , Franzoni E. , Coppola G. , et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure. 2005;14:248-253.

17.

Coppola G. , Mangano S. , Tortorella G. , et al. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res. 2004;59:35-42.

18.

Johannessen SI , Helde G. , Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia. 2005;46:775-777.

Levetiracetam for the Treatment of Neonatal Seizures

Abstract

Keywords

Get full access to this article

References